[ LabConnect raises $24.5M in Series A ]
LabConnect has raised $24.5 million in Series A funding.
Founded in 2002, LabConnect provides global central laboratory services, including routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services for biopharmaceutical, medical device and contract research organizations.
The funding will be used to fuel growth initiatives, including additional build-out of the technology platform, product and service enhancements, and sales team expansion, as well as to provide liquidity to early shareholders.
|Founder / CEO||Eric Hayashi|
|Investors||ABS Capital Partners|
|BroadOak Capital Partners|